tiprankstipranks
pc:axont

Axon Therapies

Axon Therapies is a clinical-stage medical device company focused on developing minimally invasive therapies to address the root causes of heart failure. Its proprietary approach, Splanchnic Ablation for Volume Management (SAVM), utilizes the Satera™ Ablation System to target overactivity in the sympathetic nervous system, aiming to slow disease progression and improve patient quality of life without the need for implants. The company is advancing through clinical trials to bring innovative solutions to the global heart failure market.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$32M
Total Amount Raised$32M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$32M
Latest Funding Amount$32M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 25, 2025
Series A
$32.00M

Investors

Investor Name
Funding Round

Related News and Analysis